Trial Profile
Efficacy, safety and pharmacokinetics of tipranavir + ritonavir alone, or in combination with saquinavir, amprenavir or lopinavir in patients with HIV-1 infections: a randomised controlled trial
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Jan 2013
Price :
$35
*
At a glance
- Drugs Tipranavir (Primary) ; Amprenavir; Lopinavir; Ritonavir; Saquinavir
- Indications HIV-1 infections
- Focus Pharmacogenomic; Pharmacokinetics
- Sponsors Boehringer Ingelheim